Skip to main content
SpringerLink
Log in

Fifty years of Kawasaki disease–a tribute to Dr Tomisaku Kawasaki

  • Special Article
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

It has been 50 years since the legendary Japanese pediatrician, Dr Tomisaku Kawasaki, published his classic paper in 1967. Little was he to know at that time that this condition would not only be known after his name but would also become the commonest cause of acquired heart disease in children in most of the developed world. The etiology of this condition continues to remain an enigma, and the diagnosis is still based on a set of criteria that are entirely clinical. All pediatricians must be familiar with the various clinical presentations of this disease because delays in diagnosis and treatment can have disastrous consequences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi. 1967;16:178–222.

    CAS  PubMed  Google Scholar 

  2. Burns JC. Commentary: translation of Dr Tomisaku Kawasaki’s original report of fifty patients in 1967. Pediatr Infect Dis J. 2002;21:993–5.

    Article  PubMed  Google Scholar 

  3. Burns JC, Kushner HI, Bastian JF, Shike H, Shimizu C, Matsubara T, et al. Kawasaki disease: A brief history. Pediatrics. 2000;106:e27.

    Article  CAS  PubMed  Google Scholar 

  4. Kawasaki T. Pediatric acute febrile mucocutaneous lymph node syndrome with characteristic desquamation of fingers and toes: my clinical observation of fifty cases. Pediatr Infect Dis J. 2002;21:1–38.

    Article  Google Scholar 

  5. Kato H, Koike S, Yamamoto M, Ito Y, Yano E. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr. 1975;86:892–8.

    Article  CAS  PubMed  Google Scholar 

  6. Tanaka N, Naoe S, Masuda H, Ueno T. Pathological study of sequelae of Kawasaki disease (MCLS) with special reference to the heart and coronary arterial lesions. Acta Pathol Jpn. 1986;36:1513–27.

    CAS  PubMed  Google Scholar 

  7. Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, et al. Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: From the results of the 22nd nationwide survey. J Epidemiol. 2015;25:239–45.

    Article  PubMed  Google Scholar 

  8. Singh S, Vignesh P, Burgner D. The epidemiology of Kawasaki disease: a global update. Arch Dis Child. 2015;100:1084–8.

    Article  PubMed  Google Scholar 

  9. Kim GB, Park S, Eun LY, Han JW, Lee SY, Yoon KL, et al. Epidemiology and clinical features of Kawasaki disease in South Korea, 2012-2014. Pediatr Infect Dis J. 2017;36:482–5.

    Article  PubMed  Google Scholar 

  10. Lin MC, Lai MS, Jan SL, Fu YC. Epidemiologic features of Kawasaki disease in acute stages in Taiwan, 1997-2010: Effect of different case definitions in claims data analysis. J Chin Med Assoc. 2015;78:121–6.

    Article  PubMed  Google Scholar 

  11. Du ZD, Zhang T, Liang L, Meng X, Li T, Kawasaki T, et al. Epidemiologic picture of Kawasaki disease in Beijing from 1995 through 1999. Pediatr Infect Dis J. 2002;21:103–7.

    Article  PubMed  Google Scholar 

  12. Li X, Li X, Li H, Xu M, Zhou M. Epidemiological survey of Kawasaki disease in Sichuan province of China. J Trop Pediatr. 2008;54:133–6.

    Article  PubMed  Google Scholar 

  13. Du ZD, Zhao D, Du J, Zhang YL, Lin Y, Liu C, et al. Epidemiologic study on Kawasaki disease in Beijing from 2000 through 2004. Pediatr Infect Dis J. 2007;26:449–51.

    Article  PubMed  Google Scholar 

  14. Ma X, Yu C, Huang M, Chen S, Huang M, Huang G, et al. Epidemiologic features of Kawasaki disease in Shanghai from 2003 through 2007. Chin Med J (Engl). 2010;123:2629–34.

    PubMed  Google Scholar 

  15. Chen J-J, Ma X-J, Liu F, Yan W-L, Huang M-R, Huang M, et al. Epidemiologic features of Kawasaki disease in Shanghai from 2008 through 2012. Pediatr Infect Dis J. 2016;35:7–12.

    PubMed  Google Scholar 

  16. Singh S, Aulakh R, Bhalla AK, Suri D, Manojkumar R, Narula N, et al. Is Kawasaki disease incidence rising in Chandigarh, North India? Arch Dis Child. 2011;96:137–40.

    Article  PubMed  Google Scholar 

  17. Singh S, Bhattad S. Kawasaki disease incidence at Chandigarh, North India, during 2009-2014. Rheumatol Int. 2016;36:1391–7.

    Article  PubMed  Google Scholar 

  18. Kushner HI, Macnee R, Burns JC. Impressions of Kawasaki syndrome in India. Indian Pediatr. 2006;43:939–42.

    PubMed  Google Scholar 

  19. Burns JC. Kawasaki Disease update. Indian J Pediatr. 2009;76:71–6.

    Article  PubMed  Google Scholar 

  20. Kumar RK, Tandon R. Rheumatic fever & rheumatic heart disease: The last 50 years. Indian J Med Res. 2013;137:643–58.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Newburger JW, Takahashi M, Burns JC. Kawasaki Disease. J Am Coll Cardiol. 2016;67:1738–49.

    Article  PubMed  Google Scholar 

  22. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American Heart Association. Circulation. 2017;135:e927–99.

    Article  PubMed  Google Scholar 

  23. Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int. 2005;47:232–4.

    Article  PubMed  Google Scholar 

  24. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and longterm management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747–71.

    Article  PubMed  Google Scholar 

  25. Singh S, Sharma A, Jiao F. Kawasaki Disease: Issues in diagnosis and treatment—A developing country perspective. Indian J Pediatr. 2016; 83:140–5.

    Article  PubMed  Google Scholar 

  26. Vijayvergiya R, Bhattad S, Varma S, Singhal M, Gordon J, Singh S. Presentation of missed childhood Kawasaki disease in adults: Experience from a tertiary care center in north India. Int J Rheum Dis. 2017;20:1023–7.

    Article  PubMed  Google Scholar 

  27. Singh S, Agarwal S, Bhattad S, Gupta A, Suri D, Rawat A, et al. Kawasaki disease in infants below 6 months: A clinical conundrum? Int J Rheum Dis. 2016;19:924–8.

    Article  CAS  PubMed  Google Scholar 

  28. Salgado AP, Ashouri N, Berry EK, Sun X, Jain S, Burns JC, et al. High risk of coronary artery aneurysms in infants younger than 6 months of age with Kawasaki disease. J Pediatr. 2017;185:112–6.

    Article  PubMed  Google Scholar 

  29. Singh S, Kawasaki T. Kawasaki disease in India, lessons learnt over the last 20 years. Indian Pediatr. 2016;53:119–24.

    Article  PubMed  Google Scholar 

  30. Youn Y, Kim J, Hong YM, Sohn S. Infliximab as the first retreatment in patients with Kawasaki disease resistant to initial intravenous immunoglobulin. Pediatr Infect Dis J. 2016;35:457–9.

    Article  PubMed  Google Scholar 

  31. Singh S, Sharma D, Suri D, Gupta A, Rawat A, Rohit MK. Infliximab is the new kid on the block in Kawasaki disease: A single-centre study over 8 years from North India. Clin Exp Rheumatol. 2016;34:S134–138.

    PubMed  Google Scholar 

  32. Dusser P, Koné-Paut I. IL-1 inhibition may have an important role in treating refractory Kawasaki disease. Front Pharmacol. 2017;8:163.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Rizk SRY, El Said G, Daniels LB, Burns JC, El Said H, Sorour KA, et al. Acute myocardial ischemia in adults secondary to missed Kawasaki disease in childhood. Am J Cardiol. 2015;115:423–7.

    Article  PubMed  Google Scholar 

  34. Waterhouse BR, Tulloh RMR, Kim Y, Creasy W, Adlam D, Johnson TW. Retrospective study of the impact of unrecognised Kawasaki disease, coronary aneurysm and ectasia. Int J Cardiol. 2017;248:308–13.

    Article  PubMed  Google Scholar 

  35. Agarwal S, Agrawal DK. Kawasaki disease: etiopathogenesis and novel treatment strategies. Expert Rev Clin Immunol. 2017;13:24758.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Advanced Pediatrics Centre, PGIMER, Chandigarh, India

    Surjit Singh & Ankur Kumar Jindal

Authors
  1. Surjit Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ankur Kumar Jindal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Surjit Singh.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singh, S., Jindal, A.K. Fifty years of Kawasaki disease–a tribute to Dr Tomisaku Kawasaki. Indian Pediatr 54, 1037–1039 (2017). https://doi.org/10.1007/s13312-017-1208-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-017-1208-x

Keywords

Search

Navigation